Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
Atenolol (Tenormin)

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Category:

  • Nervous system

Description:

  • Antihypertensive, antianginal, class II antidysrhythmic: (beta blocker)

Indications:

  • Angina pectoris due to coronary atherosclerosis,

  • Hypertension, acute MI

  • Several non-FDA approved uses

Contraindications:

  • Cardiogenic shock, 2nd or 3rd degree heart block, sinus bradycardia

  • CHF unless secondary to a tachyarrhythmia treatable with beta-blockers, overt cardiac failure

Precautions:

  • Pregnancy category C

  • Major surgery, diabetes mellitus, renal disease, thyroid disease, COPD, asthma

  • Well compensated heart failure, abrupt withdrawal, peripheral vascular disease

  • Do not discontinue drug abruptly, may precipitate angina

Adverse Reactions (Side Effects):

  • CNS: depression, dizziness, drowsiness, fatigue, hallucinations, insomnia, lethargy, memory loss, mental changes, strange dreams

  • CV: bradycardia, CHF, cold extremities, postural hypotension, profound hypotension, 2nd and 3rd degree heart block

  • EENT: dry burning eyes, sore throat visual disturbances

  • GI: diarrhea, dry mouth, ischemic colitis, mesenteric arterial thrombosis, nausea, vomiting

  • GU: impotence, sexual dysfunction

  • HEME: agranulocytosis, thrombocytopenia

  • METAB: hyperglycemia, hyperlipidemia, masked hypoglycemic response

  • RESP: bronchospasm, dyspnea, wheezing

  • SKIN: alopecia, pruritis, rash  

Dosage:

Administered orally and intravenously

  • Adult: 

    • IV 

      • 5mg over 5 min

      • repeat in 10 minutes if initial dose is well tolerated

      • then start PO dose 10 minutes after last IV dose

    • PO 

      • 50mg daily

      • increase every 1-2 weeks to 100mg daily

      • may increase to 200mg daily for angina

  • Child: 

    • PO 

      • initial 1-1.2 mg/kg/dose given daily

      • maximum 2 mg/kg/day

 

 


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products